Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

PRC961

Prostate cancer tissue array, 48 cases/96 cores
Unstained: $210.00 Add to Cart

Microarray Panel:Prostate carcinoma tissue microarray, including 48 cases of normal, premalignant and cancer tissues, duplicated cores per case
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:4 µm
Quality Control:H&E, IHC anti- Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Gleason Score TNM Type †
A1 1 M 67 Prostate Hyperplasia Hyperplasia Benign
A2 2 M 79 Prostate Hyperplasia Hyperplasia Benign
A3 3 M 71 Prostate Hyperplasia Hyperplasia Benign
A4 4 M 68 Prostate Hyperplasia Hyperplasia Benign
A5 5 M 67 Prostate Hyperplasia Hyperplasia Benign
A6 6 M 58 Prostate Hyperplasia Hyperplasia Benign
A7 7 M 78 Prostate Hyperplasia Hyperplasia Benign
A8 8 M 60 Prostate Hyperplasia Hyperplasia Benign
A9 9 M 67 Prostate Hyperplasia Hyperplasia Benign
A10 10 M 69 Prostate Hyperplasia Hyperplasia Benign
A11 11 M 68 Prostate Hyperplasia Hyperplasia Benign
A12 12 M 67 Prostate Hyperplasia Hyperplasia Benign
B1 13 M 67 Prostate Hyperplasia Hyperplasia Benign
B2 14 M 79 Prostate Hyperplasia Hyperplasia Benign
B3 15 M 71 Prostate Hyperplasia Hyperplasia Benign
B4 16 M 68 Prostate Hyperplasia Hyperplasia Benign
B5 17 M 67 Prostate Hyperplasia Hyperplasia Benign
B6 18 M 58 Prostate Hyperplasia Hyperplasia Benign
B7 19 M 78 Prostate Hyperplasia Hyperplasia Benign
B8 20 M 60 Prostate Hyperplasia Hyperplasia Benign
B9 21 M 67 Prostate Hyperplasia Hyperplasia Benign
B10 22 M 69 Prostate Hyperplasia Hyperplasia Benign
B11 23 M 68 Prostate Hyperplasia Hyperplasia Benign
B12 24 M 67 Prostate Hyperplasia Hyperplasia Benign
C1 25 M 74 Prostate Adenocarcinoma Malignant 4 Malignant
C2 26 M 59 Prostate Adenocarcinoma Malignant 4 I Malignant
C3 27 M 69 Prostate Adenocarcinoma Malignant 4 Malignant
C4 28 M 77 Prostate Adenocarcinoma Malignant 4 Malignant
C5 29 M 60 Prostate Adenocarcinoma Malignant 5 II Malignant
C6 30 M 76 Prostate Adenocarcinoma Malignant 6 II Malignant
C7 31 M 61 Prostate Adenocarcinoma Malignant 5 II Malignant
C8 32 M 73 Prostate Adenocarcinoma Malignant 5 II Malignant
C9 33 M 73 Prostate Adenocarcinoma Malignant 8 II Malignant
C10 34 M 88 Prostate Adenocarcinoma Malignant 6 II Malignant
C11 35 M 69 Prostate Adenocarcinoma Malignant 7 III Malignant
C12 36 M 47 Prostate Adenocarcinoma Malignant 8 III Malignant
D1 37 M 74 Prostate Adenocarcinoma Malignant 4 Malignant
D2 38 M 59 Prostate Adenocarcinoma Malignant 4 I Malignant
D3 39 M 69 Prostate Adenocarcinoma Malignant 4 Malignant
D4 40 M 77 Prostate Adenocarcinoma Malignant 4 Malignant
D5 41 M 60 Prostate Adenocarcinoma Malignant 5 II Malignant
D6 42 M 76 Prostate Adenocarcinoma Malignant 6 II Malignant
D7 43 M 61 Prostate Adenocarcinoma Malignant 4 II Malignant
D8 44 M 73 Prostate Adenocarcinoma Malignant 5 II Malignant
D9 45 M 73 Prostate Adenocarcinoma Malignant 8 II Malignant
D10 46 M 88 Prostate Adenocarcinoma Malignant 6 II Malignant
D11 47 M 69 Prostate Adenocarcinoma Malignant 7 III Malignant
D12 48 M 47 Prostate Adenocarcinoma Malignant 8 III Malignant
E1 49 M 67 Prostate Adenocarcinoma Malignant 6 II~III Malignant
E2 50 M 70 Prostate Adenocarcinoma Malignant 8 Malignant
E3 51 M 70 Prostate Adenocarcinoma Malignant 6 II Malignant
E4 52 M 77 Prostate Adenocarcinoma Malignant 8 III Malignant
E5 53 M 75 Prostate Adenocarcinoma Malignant 7 II Malignant
E6 54 M 51 Prostate Adenocarcinoma Malignant 5 Malignant
E7 55 M 54 Prostate Adenocarcinoma Malignant 8 II Malignant
E8 56 M 77 Prostate Adenocarcinoma Malignant 8 II Malignant
E9 57 M 78 Prostate Adenocarcinoma Malignant 8 Malignant
E10 58 M 77 Prostate Adenocarcinoma Malignant 9 II Malignant
E11 59 M 77 Prostate Adenocarcinoma Malignant 8 II~III Malignant
E12 60 M 73 Prostate Adenocarcinoma Malignant 9 Malignant
F1 61 M 67 Prostate Adenocarcinoma Malignant 6 II~III Malignant
F2 62 M 70 Prostate Adenocarcinoma Malignant 8 Malignant
F3 63 M 70 Prostate Adenocarcinoma Malignant 6 II Malignant
F4 64 M 77 Prostate Adenocarcinoma Malignant 8 III Malignant
F5 65 M 75 Prostate Adenocarcinoma Malignant 7 II Malignant
F6 66 M 51 Prostate Adenocarcinoma Malignant 5 Malignant
F7 67 M 54 Prostate Adenocarcinoma Malignant 8 II Malignant
F8 68 M 77 Prostate Adenocarcinoma Malignant 8 II Malignant
F9 69 M 78 Prostate Adenocarcinoma Malignant 8 Malignant
F10 70 M 77 Prostate Adenocarcinoma Malignant 9 II Malignant
F11 71 M 77 Prostate Adenocarcinoma Malignant 8 II~III Malignant
F12 72 M 73 Prostate Adenocarcinoma Malignant 9 Malignant
G1 73 M 75 Prostate Adenocarcinoma Malignant 8 III Malignant
G2 74 M 70 Prostate Adenocarcinoma Malignant 8 III Malignant
G3 75 M 79 Prostate Adenocarcinoma Malignant 8 Malignant
G4 76 M 55 Prostate Adenocarcinoma Malignant 8 II Malignant
G5 77 M 84 Prostate Adenocarcinoma Malignant 8 III Malignant
G6 78 M 73 Prostate Adenocarcinoma Malignant 9 II~III Malignant
G7 79 M 73 Prostate Adenocarcinoma Malignant 9 III Malignant
G8 80 M 77 Prostate Adenocarcinoma Malignant 9 II~III Malignant
G9 81 M 78 Prostate Adenocarcinoma Malignant 9 Malignant
G10 82 M 68 Prostate Adenocarcinoma Malignant 9 III Malignant
G11 83 M 78 Prostate Adenocarcinoma Malignant 9 III Malignant
G12 84 M 74 Prostate Adenocarcinoma Malignant 10 III Malignant
H1 85 M 75 Prostate Adenocarcinoma Malignant 8 III Malignant
H2 86 M 70 Prostate Adenocarcinoma Malignant 8 III Malignant
H3 87 M 79 Prostate Adenocarcinoma Malignant 8 Malignant
H4 88 M 55 Prostate Adenocarcinoma Malignant 8 II Malignant
H5 89 M 84 Prostate Adenocarcinoma Malignant 8 III Malignant
H6 90 M 73 Prostate Adenocarcinoma Malignant 9 II~III Malignant
H7 91 M 73 Prostate Adenocarcinoma Malignant 9 III Malignant
H8 92 M 77 Prostate Adenocarcinoma Malignant 9 II~III Malignant
H9 93 M 78 Prostate Adenocarcinoma Malignant 9 Malignant
H10 94 M 68 Prostate Adenocarcinoma Malignant 9 III Malignant
H11 95 M 78 Prostate Adenocarcinoma Malignant 9 III Malignant
H12 96 M 74 Prostate Adenocarcinoma Malignant 10 III Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal